EntityRisk

EntityRisk does not conduct clinical trials or have clinical results. Its PROVEN™ platform enables biopharma companies and investors to predict and measure the real-world value of new medical technologies by integrating clinical trial data, real-world evidence, financial data, and advanced simulation modeling[1][3]. The company’s tools are used by both large multinational pharma companies and smaller biotech firms to optimize pricing decisions, advance market access strategies, improve evidence-generation investments, and assess commercial value[5]. The PROVEN™ platform supports generalized cost-effectiveness analysis using Bayesian machine learning models[1][3]. No direct pipeline of therapeutic programs.